ArticleMicrobiology spectrum2026
Targeted Epstein-Barr virus capture sequencing identifies BBLF4-L322M as an independent prognostic variant in nasopharyngeal carcinoma.
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Epstein-Barr virus (EBV) is etiologically linked to nasopharyngeal carcinoma (NPC) and shows geographic heterogeneity. To determine whether viral genotype affects prognosis, we performed capture-based whole-genome sequencing of EBV from 114 Guangxi NPC biopsies (mean breadth ~93%, depth ~979×) with Sanger confirmation at BNRF1-G696R. We detected 5,683 high-confidence variants with a mean of 1,112 per genome enriched in latent genes (LMP1, LMP2A/B, and the EBNA family). Variants with minor allele frequency ≥0.15 and missingness ≤0.05 were tested for association with 5-year overall survival. A total of 46 loci were significant in the univariate Cox models, and 19 missense variants underwent unsupervised clustering by genotype correlation, yielding two blocks. From these, BZLF1-A205S and BBLF4-L322M were selected as the index variants. In multivariable Cox models adjusted for age and dichotomized American Joint Committee on Cancer (AJCC) stage, BBLF4-L322M remained independently associated with poorer overall survival (OS), whereas BZLF1-A205S was not significant. A 720-genome phylogeny integrating our sequences with public data showed several Chinese sublineages with partial regional structuring. Guangxi strains were closely related to, yet partly distinct from, Guangdong and Hong Kong. These results support the incorporation of the EBV genotype, particularly BBLF4-L322M, into prognostic models and motivate functional studies to define mechanisms and validate their clinical utility. IMPORTANCE: The prognostic Epstein-Barr virus (EBV) variants in nasopharyngeal carcinoma (NPC) remain largely unknown. This study presents the first genome-wide survey of EBV sequence diversity in patients with NPC in Guangxi, China. The identified mutations, including BZLF1-A205S and BBLF4-L322M, are candidate viral biomarkers linked to patient survival. The abundance of nonsynonymous variants in latent phase genes implies a role for the viral genotype in the disease course. These insights have laid the groundwork for EBV-based prognostic biomarkers and precise medical strategies tailored to endemic NPC populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.